BVA’s advice comes as the four nations of the UK launch contact tracing programmes to move from blanket lockdown restrictions to a more targeted approach, in line with strategies to ease lockdown restrictions.
Although slightly different across the UK, each programme will ask those who test positive for coronavirus to identify people they have been in recent contact with and those people will be contacted and asked to self-isolate for 14 days.
Relevant contact appears to be spending more than 15 minutes within two metres of another person or being in direct face-to-face contact (less than one metre) with them. At present, the schemes are voluntary, but may become mandatory at a later stage.
Northern Ireland: Test, trace, isolate, supportEngland: NHS Test and TraceScotland: Test and ProtectWales: Test Trace Protect
Employees in self-isolation are entitled to Statutory Sick Pay for every day they are in isolation, as long as they meet the eligibility conditions. Further roll out of testing may enable people to return to work sooner that 14 days if they receive a negative test.
BVA President Daniella Dos Santos said: "The next step in the Covid-19 response is shifting to a more targeted approach, but it’s clear that this could have a very significant impact on individual veterinary practices if a member of the team tests positive. The nature of veterinary work means we are in close contact with our colleagues in order to work safely with animals.
“Many veterinary teams will be understandably anxious about the impact on their ability to staff a full rota to maintain 24/7 care. And there are significant concerns about the impact on animal health and welfare if practices are unable to provide veterinary services.
"Our advice is to continue working in fixed pairs or small teams as much as possible to reduce your contact with different individuals and continue to practise good hygiene and biosecurity.
"We continue to ask neighbouring practices to work together to support those impacted by self-isolation and ensure full geographical cover for veterinary services.
"We recognise some veterinary professionals will be worried, but we urge everyone to comply with the contact tracing programmes."
Alan, who is MD of the veterinary business consultancy, Vet Dynamics, will be looking at finances, the team, and scoping out a future strategy. The session will provide practical planning tools, strategic advice, and the opportunity to ask questions.
Bayer points to a number of trends which have emerged during lockdown which it says practices must respond to quickly in the post-lockdown recovery.
The company says retailers have reported that internet traffic increased threefold at the start of lockdown and it remains at double the pre-lockdown levels. Direct retail sales of flea and tick products have also increased.
This suggests that owners are becoming more comfortable with buying preventative healthcare products online.
Bayer says there is a business opportunity here for practices. The subscription box market is expected to hit £1 billion by 20222, and one way practices can capitalise on this trend is by offering home-delivered flea, wormer and tick treatments.
Another business opportunity could lie in research by Banfield Pet Hospital among 1,000 US pet owners in which 20% vowed to take their pets ‘more often’ to the vet post-lockdown for preventative care checkups3.
Caroline Braidwood, Regional Business Manager of Bayer Animal Health said: "We know that many veterinary customers have potentially gone elsewhere during the pandemic and vets will need to work hard to win them back. Our webinar will provide tangible insights to ensure that practices can flourish. Whether you’ve worked with Bayer or not, our team of Veterinary Business Managers are here to help. We’re all in this together, and with some planning, we can ensure the veterinary industry continues to grow.”
To book your webinar place, visit: https://event.webinarjam.com/register/46/rk71qav5
This year, there are 3 RVN seats and 2 Student seats available.
The RVN candidates for three available seats are: Kimberley Boparai, Felicity Caldwell, Victoria Foulkes, Declan Jones, Krishna Mistry and Cheryl Plimmer
The Student candidates for two available seats are: Kate Davies, Julia Hamilton, Poppy Meredith and Ell Stokes
BVNA President, Charlotte Pace said: “It takes courage and dedication to run for BVNA Council, and the lucky candidates will be shaping the direction of veterinary nursing.
"Now is when our members have the chance to vote for the people that they think will represent their voice best on BVNA Council for the next 3 years.
"I would urge everyone to read the manifestos, engage with the social media content throughout the election period, and vote.”
www.bvna.org.uk/blog/bvna-council-elections-2023--candidates-announced
Charlotte will share practical advice on achieving successful transfusions, in particular looking at how to overcome the challenges in sourcing blood products, especially for feline patients.
The presentation will cover:
There'll be a live Q&A session with Charlotte at the end, when Horiba's experts will also be available to answer veterinary diagnostics-related questions.
https://horiba.link/canine-and-feline-blood-transfusions.
The webinars will take place every Wednesday at 7pm in May.
David Bardell is a European and Royal College of Veterinary Surgeons Specialist in Veterinary Anaesthesia and Analgesia and will be hosting the first two sessions covering equine pain management for colic and orthopaedic cases respectively.
The 5th May webinar will cover how to recognise and understand the pathology of visceral pain, physical and pharmacological methods of analgesia and dealing with violent or difficult colic cases.
The second webinar on the following Wednesday, will look at how to recognise and quantify pain, the use of pain scales, analgesic medication and techniques.
The other two sessions of the series will be led by Dr. Andy Fiske-Jackson, Deputy Head of RVC Equine and Senior Lecturer in Equine Surgery at the Royal Veterinary College. He'll be running case-based sessions looking at the good, bad and ugly of digital flexor tendon sheath cases and unravelling the diagnosis and treatment of navicular syndrome, the associated biomechanics and treatment options respectively.
Emma Jennings, Equine Brand Manager at Dechra (pictured right) said: “The broad scope of illnesses and conditions facing those specialising in equine care means that it’s important to delve deeper into some key issues, which is what this series of webinars will do.
“We hope the expertise of David Bardell and Dr. Andy Fiske-Jackson will be of key interest to veterinary professionals across the country and would urge anyone interested to register for the sessions throughout May.”
To register for the free webinars, visit www.dechra.co.uk/events.
The operation of the equipment is being overseen by Dr Rodney Ayl, a specialist in both medical and radiation oncology. He said: "The need for protection of personnel during preparation of cytotoxic drugs presents the most significant obstacle to the safe provision of chemotherapy, as most practices are not equipped with an appropriate biosafety cabinet. This is especially true when there is a high case-load of chemotherapy patients."
Dr Ayl says the dangers of repeatedly handling and administering cancer drugs can be severe. He added: “The likelihood of drug exposure must be taken into account when considering the safety of personnel who handle cytotoxic drugs.
"The cumulative toxicity to personnel that arises from repeated contact with these drugs can cause health problems in the nursing staff that are beyond those expected in the patient.
"The main routes of personnel exposure to cytotoxic drugs are by aerosolisation or by absorption through skin.
"Both types of exposure can occur when preparing drugs for administration. The act of withdrawing cytotoxic drug from the vial into a syringe is generally the step that presents personnel with the greatest potential for exposure to a high concentration of drug.
"Ideally, personnel are optimally protected from drug exposure, and patients are protected from contamination of the product, by the use of a laminar flow biosafety cabinet (BCS) during drug preparation, regardless of whether a closed delivery system is used.
"The Envair CytoFAST BSC has been designed to guarantee the product, personnel and environmental protection.
"It belongs to the latest generation of laminar airflow systems and is built to the highest quality to guarantee the strictest safety standards - and the safety of our people is paramount at Paragon."
The open day will cover topics including radiography, wounds and TPLO surgery aftercare, hosted by Dr. Michael Hamilton, consultant orthopaedic and spinal surgeon, Dr Karla Lee, head of soft tissue surgery and Letty Piggott-Delves, physiotherapy team lead.
There will also be an IMHA case discussion with internal medicine nurse Rute Silva, and an interactive quiz on anaesthesia for attendees to take part in, led by anaesthesia nurse practitioner Kimberley Brady.
Rachel Pickles, clinical services manager at Hamilton Specialist Referrals, said: “The open day is a brilliant opportunity for nurses from all over the veterinary profession to build on their existing knowledge base.
"It also presents an excellent learning opportunity for student nurses too, giving them access to educational sessions and workshops with members of our expert team.”
For more information and to RSVP, email info@hamiltonspecialists.vet or call 01494 578 566.
www.hamiltonspecialists.vet.
The new Chestergates ophthalmology service will offer a wide range of treatments for eye conditions, including: cryotherapy, corrective lid surgery, rhytidectomy, nasal fold ablation, cherry eye and scrolled cartilage, keratotomy, keratectomy, pedicle conjunctival graft, corneo-conjunctival transposition, bioimplants for corneal reconstruction, glaucoma diagnosis and monitoring, management of dry eye (KCS) and neurological dry eye, retro-bulbar disease investigation and treatment, cataract assessment, and intracapsular lens extraction.
The service will be led by Chestergates Advanced Practitioner in Ophthalmology, Endika Garcia MRCVS DVM PGCertSAOphthal.
Endika graduated in 2016 from the University of Valencia, completed a rotating internship, then worked for a few years in different hospitals in Spain, before moving to the UK, enrolling on the BSAVA Certificate in Small Animal Ophthalmology and being awarded Advanced Practitioner status.
Endika will be supported by a 25 strong specialist nursing team, four nurse students, one lab technician, two sterile technicians and a team of receptionists and support colleagues.
Consultations and surgical procedures will be offered at Chestergates Veterinary Specialists on Mondays and Thursdays between 8am and 5pm.
https://chestergates.org.uk/referral-services
Brian (pictured right), said: “I am absolutely delighted that Colourful CPD has joined Agilio and I see this as a win-win-win for Colourful CPD, Agilio and the veterinary profession.
"Colourful CPD’s courses complement Agilio’s vast array of existing statutory and mandatory courses which they already distribute within the UK as well as all around the world, thus enabling Colourful CPD to make the move up to the next level, both here and abroad.
I believe veterinary practices, as well as all the roles working within them, will benefit from being able to access a range of new courses and management services from Agilio.”
To mark its expansion into the veterinary sector, Agilio will be launching iTeam, its HR and rota software, together with iLearn, an online training and CPD accredited platform at the London Vet Show in November.
https://www.colourfulcpd.comhttps://agiliosoftware.com
The company points to a survey of 1000 dog owners it conducted in July which found that 77% would put many of the top ten signs of Cushing's down to ‘old age’.
According to research carried out by CM research in July 2018, for every 100 cases of Cushing’s syndrome treated, a further 57 are suspected but not diagnosed.
The ‘Prime Suspects’ campaign will encourage dog owners to become a ‘Cushing’s Detective’ and look out for signs in their dogs.
To help, the company has developed a series of characters to illustrate the signs of Cushings: Panting Patsy, Leaky Larry, Lazy Lynn, Greedy Gus and Little Patch.
A nationwide pet-focused multimedia campaign will support the ‘Prime Suspects’ initiative and will include TV and print advertising, online banners, pay per click advertising and social media to engage owners and encourage them to seek advice from their vet if they suspect Cushing’s in their dog.
Dechra has also launched Cushing’s Connect, a digital platform single resource hub to help vets keep up to date with current best practice in managing Cushing’s.
The hub has information and tools to enhance diagnostic protocols, advice and literature covering pathophysiology, diagnosis and ongoing case management including treatment protocols and monitoring schedules, and interactive guides and videos by top veterinary specialists.
There's also a client communication toolkit with owner-focused resources to encourage dog owners to spot the signs and seek help from their vet.
https://www.dechra.co.uk/cushings-connect
Lax-a-Past is a palatable paste that can be administered orally to kittens and cats aged over 6 months.
It can be used weekly to help stop hairballs from forming or in higher doses over a consecutive three-day period to help eliminate them.
Carol Morgan, Brand Manager from Dechra Veterinary Products (pictured right) said: “Hairballs are a well-known issue for cats. Lax-a-Past is a complementary feed that offers a simple, easy-to-administer solution to help relieve the digestion problems caused by hairballs.
“It is very easy for owners to administer as the required dosage can be squeezed out and spread on a front paw or given directly into the mouth."
Lax-a-Past is available in a 70g tube.
For more information visit www.dechra.co.uk.
The new system integrates with the Merlin practice management system and pet owners can access the MWI Pet portal to view and book available appointments with their veterinary surgeon via any connected device.
David Tinsley, Vice President, MWI Animal Health U.K., said: “As providers continue to navigate a changing industry and evolving consumer expectations, veterinary practices need access to technologies that help them better serve the needs of both their staff and their clients.
“MWI Pet will help practices meet consumer demands for digital-driven convenience and foster deeper relationships with their clients, while freeing up more time for staff to focus on delivering high-quality care.”
To set up a demo of the new system: https://abc1.jotform.com/222564512240850
APPA is an oral, patented, fixed-dose combination of two synthetic secondary metabolites of plant origin, apocynin and paenol.
Under the terms of the agreement, AKL’s unnamed partner will fund a study in dogs with naturally occurring OA. The study will compare the efficacy and efficacy duration of APPA with the current standard of care for treating canine OA: non-steroidal anti-inflammatory drugs.
David Miles, AKLRD CEO, said: “Just like humans, millions of dogs suffer intolerable pain and disability because of OA and the current treatments just aren’t as effective or as well tolerated as they need to be. We already know from previous canine studies that APPA reduces pain and has an excellent tolerability profile but this exciting new partnership will allow us to go one stage further and assess sustainability of response.”
The randomised study will assess pain and duration of response as the primary endpoint. Secondary endpoint assessment will include adverse events, quality of life, pharmacokinetics analysis and biomarkers that may enable potential identification of factors predictive of response at treatment onset, or that correlate with response magnitude.
Two separate studies on dogs have already been carried out by researchers at the University of Vienna. The first, an 11-week cross-over study of 32 canines diagnosed with established, naturally occurring OA, showed that APPA provides significant symptom relief in clinical canine OA1.
A follow-up, five-week study of 60 dogs with OA compared APPA to the standard of care drug, meloxicam. It concluded that daily oral administration of APPA was effective as a stand-alone alternative to NSAIDs in dogs with naturally occurring OA. Significant benefits were also seen for APPA over meloxicam in orthopaedic examination as well as in lameness and function scores2.
The results will inform the pivotal clinical trial design and AKL says its working assumption is that a 26-week field study would complete the regulatory requirements for commercialisation.
If the study and future testing is successful, AKL estimates that APPA would be well placed to capture a significant share of the global canine OA market, which is estimated to be worth $3billion by 20283.
References
Willows says it is currently the only centre in the UK to offer the procedure, and one of very few in the world.
Simon Swift, an RCVS and European specialist in small animal cardiology (pictured right), heads the cardiology team at Willows.
He said: “Transcatheter edge-to-edge mitral valve repair (TEER) is already considered an alternative to surgical repair in human patients and there have been some very promising early clinical results in dogs.
“The procedure is performed under general anaesthesia through a small incision in the chest wall.
“Access within the beating heart is achieved by a needle puncture at the apex of the heart which is highlighted by continuous X-ray images and an ultrasound of the heart via a probe placed in the oesophagus.
“This allows correct positioning of a V-clamp across the mitral valve to reduce the amount of leakage.
“It’s a procedure that delivers meaningful results and an improved quality of life and, because it’s a minimally invasive process, patients are typically discharged from hospital within two days.”
www.willows.uk.net
Teleradiology company, VetCT, is calling for companies developing and deploying AI in the field of veterinary diagnostic imaging to impose the highest standards of self-regulation. In an AI position statement released on their website, the company highlights the opportunities and risks associated with the use of AI to interpret diagnostic images.
In the joint statement, company owners Victoria Johnson and Julien Labruyère (pictured right), said: “We strongly welcome the introduction of appropriately developed, tested and implemented AI tools into our profession, to provide solutions to improve resourcing and benefit animal welfare.
“There is a limited pool of veterinary radiologists and an ever-increasing need for expert interpretation of radiographs and more advanced diagnostic imaging modalities.
"This presents a huge opportunity for the development of AI and related technologies to better address demand, save time and potentially improve clinical knowledge and outcomes.
"However, it is important to note that, unlike human radiology, there is no official framework for the regulation, governance and quality control of AI tools in veterinary radiology.
"This means that there should be a very strong onus on companies and individuals to adhere to the highest standards of medical tool development when creating AI solutions.”
“If AI is released into veterinary practice without appropriate oversight or governance there is a significant risk of misleading results, misdiagnosis, and negative impacts on patient welfare.
"This, in turn, may undermine trust in AI and create a culture of hesitancy to adopt new technologies at a time when innovation is much needed to improve access to advanced care.”
The company is advocating for a series of self-regulatory measures to be applied by companies developing AI in order to safeguard both animal welfare and the liability of the veterinary surgeons using these tools in clinical practice.
The full position statement and a list of recommendations can be here: https://www.vet-ct.com/gb/our-services/ai-veterinary-radiology/
A few examples of the products in J.A.K Marketing's 'ThinkGreen' portfolio include the Purfect Anaesorber, BAG’EMS biodegradable poop bags, Tick Twister products (made from recycled plastic) and Bamboo stick cotton buds.
The website also gives a snapshot of the sorts of things that J.A.K itself does to reduce its impact on the environment, including the use of environmentally-friendly brown paper and recycled cardboard boxes for packaging. The company has also switched to certified sustainable FSC paper for most of its printed marketing materials (including the master catalogue) and is working with courier companies who have targets in reducing CO2 emissions.
Managing Director, John Holland said: "J.A.K Marketing is committed to the protection and preservation of the world’s ecosystem. By undertaking our productivity and operations responsibly and sustainably, we recognise that reducing the environmental impact of our activities is very important. We will strive to achieve environmental excellence within the veterinary industry and will continue to work closely with our employees and commercial partners to establish and follow the principles of our ThinkGreen policy."
Sales Director, James Johnson said: "With growing interest towards the protection of the environment, we need to make it easier for veterinary practices to identify products where there is a benefit to the environment by simply switching to a like for like ‘greener’ alternative. As part of our long-term strategy, we are dedicated to growing this area of our business, welcoming feedback from the profession of how we can all work together to achieve this."
Those wanting to offer inspiration and feedback can do so on the form at the bottom of the ‘ThinkGreen’ page: www.jakmarketing.co.uk/thinkgreen.
Preliminary results, which recorded a decline in the quantities of antimicrobials prescribed from 2014 to 2018, were published in 2022.
A further audit has now been undertaken in all 22 of the company's first opinion practices to investigate the age, breed and estimated weight of each horse, the clinical indication for antibiotic use, the drugs prescribed, their dose rates, the route of administration and whether culture and sensitivity were used to guide antimicrobial selection.
Data collection was completed in August 2022.
This secondary audit was conducted using a ‘point prevalence’ survey, in which each CVS Equine first opinion Quality Improvement Lead gathered information about all systemic antibiotics prescribed by each of their practices on one day a month for 12 consecutive months.
The project yielded information on 331 cases where systemic antimicrobials were prescribed.
Complete data about the first line-drug selection were available for 261 prescriptions.
The commonest prescribed antimicrobial was sulfadiazine/trimethoprim (41%), followed by oxytetracycline (23%), procaine penicillin (16%), doxycycline (13%), gentamicin (4%), metronidazole (1%), ceftiofur (1%) and enrofloxacin (1%).
Highest priority critically important antimicrobials (ceftiofur and enrofloxacin) were only prescribed in four horses (clinical indications for these included possible sepsis, skin infection, lower respiratory tract infection and a wound complication – in none of these cases was the first-line drug selection based on the results of culture and sensitivity.
Overall, the clinical indications for antimicrobial use were recorded in 246 cases; the commonest indications were cellulitis/lymphangitis (27%), uncomplicated wounds (19%), surgical prophylaxis (15%), respiratory infections (11%) and skin infections (8%).
Hattie Lawrence, Director of CVS Equine, said: “Though the impact of this work is yet to be documented, there is anecdotal evidence that it has raised awareness amongst our veterinarians of the importance of antimicrobial stewardship.
"Taken together, the results of both pieces of work will be used to help develop and inform clinical audits and clinical guidelines of antimicrobial use in horses.”
Reference
Exclusive to veterinary practices, the new range targets specific health concerns, allowing vets and nurses to offer clients preventative nutrition advice to help their pets maintain a healthy lifestyle.
The Adult diets are designed to support healthy digestion and muscle health with high-quality protein at an attractive price. The wet foods come in cans for dogs and pouches for cats. Meanwhile, as the name suggests, No Grain contains no grain or gluten, to support healthy digestion, vital organ health and a healthy skin and coat.
Hill's says the new products also include a high level of antioxidants to support natural defences and omega-6 fatty acids for healthy skin and a luxurious coat.
For more information, visit: www.hillspet.co.uk/vetessentials
The new suite offers chemotherapy and radiotherapy treatment facilities under one roof, including a linear accelerator (LINAC) which enables treatment of tumours previously considered untreatable.
Southfields has two full-time client-facing specialists in radiation oncology and two on-site, full-time double-boarded medical and radiation oncologists, along with dedicated radiotherapy technicians and therapeutic radiographers.
RCVS and European Specialist Sarah Mason, Southfield's lead in general oncology, said: “Southfields is already renowned as being the leader in cancer treatment for small animals in the UK and the opening of our dedicated oncology and radiotherapy suite takes patient care to an even higher level.”
www.southfields.co.uk
This brings the total reported the UK so far this year to eight, following 28 last year and 287 in total.
For a map of all confirmed cases and information for veterinary professionals and pet owners about CRGV, visit: www.alabama-rot.co.uk.
The talk, entitled “Rabbit Dentistry: It Takes Two”, will be co-presented by Craig Tessyman, an exotics veterinary nurse who works alongside Molly at Rutland House Referral Hospital. Their talk will cover the diagnosis and management of dental disease. It is aimed at any veterinary surgeon or nurse who wants to learn more about best practice in rabbit dentistry.
Molly, who holds both a Certificate and Diploma in Zoological Medicine, said: "Dental disease is common amongst pet rabbits, so small animal vets often need to diagnose and treat dental problems.
"It can be challenging to manage these cases. Our aim with this talk is to help vets improve their clinical approach, and also to provide useful tips for nurses – we want to explain how the practice team can work together with these cases, along our theme of ‘it takes two’."
Molly and Craig’s presentation will cover relevant background on the mechanisms of chewing in rabbits and provide practical advice on recognising and diagnosing dental disease. Physical examination and dental charting will be discussed, as well as dental radiography.
Molly said: "Radiography can be a really useful tool to assess dental disease in rabbits. Vets often aren’t as familiar with positioning and evaluating radiographs of rabbits as compared to cats and dogs, so we’ll give some useful tips on what to look out for."
Molly will share some advice on taking good dental radiographs, and then go into the details of interpretation, explaining how to use imaging to gain a more accurate diagnosis and enable more specific treatment. After this, she will discuss how best to plan and perform dental treatment. Incisor removal, cheek tooth extraction and pulpectomy are some of the topics she’ll cover.
The talk counts for 1 hour of CPD and will be held on 11th November at 12:20pm. Those who can’t make the live session can access a recording afterwards. More information and the sign-up link is available here: https://supremepetfoods.com/rabbit-dentistry-it-takes-two/.
Otomicol contains miconazole nitrate, prednisolone acetate and polymyxin B.
The product targets a range of pathogens including miconazole and polymyxin B-sensitive, Malassezia and Pseudomonas spp.
Renzo Di Florio, technical vet at Krka UK, said: “With its multifactorial aetiology, ear disease is often challenging to manage, causing frustration for owners and significant discomfort for pets.
"Otomicol is a cost-effective solution that veterinary surgeons can add to their treatment toolbox for cases where bacterial and fungal infection are important factors.”
Otomicol ear drops and cutaneous suspension are available in a 15ml bottle with an extended shelf life of six months after opening.
Otomicol is available from veterinary wholesalers.
https://www.krka.co.uk
The aim of the Leadership Stories initiative is to present the perspectives of people from diverse and minority backgrounds so that they see themselves reflected in leadership roles within the profession.
RCVS Leadership and Inclusion Manager, Gurpreet Gill, said: "We decided to release this video as part of Veterinary Nursing Awareness Month to show people exactly what a career in veterinary nursing can lead to.
"Betsy has achieved a huge amount in a relatively short space of time and is a great example of what can happen when you blend personal values, professional knowledge and excellent people skills to deliver effective leadership.”
“The theme for Veterinary Nursing Awareness Month this year is ‘progression’, and we hope that this film will inspire members of the veterinary community, or those aspiring to become members, to find their own inner leaders.
"There are so many different opportunities working in the veterinary sector, but it’s often difficult to know what could be possible.
“We hope that by sharing the leadership stories of people like Betsy, we can help demystify the landscape slightly and help to show people that there are many opportunities out there that they may not have previously considered or even be aware of.”
Betsy said: “It was a brilliant opportunity to work with the team at the RCVS on such an important project.
"As I’ve mentioned, whether it’s specialising, leadership, teaching or research, RVNs have so many transferable skills that can be used across the sector in many different roles.
“Coming from an ethnic minority background myself, it has been very clear that the profession isn’t very diverse and that we need to do more to proactively promote veterinary nursing and veterinary medicine as viable career options in schools from a younger age.
“When it comes to leadership, I think initiatives such as the RCVS Leadership Stories are great in terms of showcasing diverse leaders and career opportunities.
"People need to be able to see themselves in these roles, to see that it is possible.
"We are making progress, but we still have a long way to go.”
https://www.youtube.com/watch?v=XSgg8xeHyp4&list=PLwm3GH0FNPl30FXR3k688HSNzeaKxMwD9&index=4
The pack highlights the benefits of Adaptil and Feliway and Ceva’s ThunderShirt range of calming wraps.
It contains a wall/notice board display, a poster, an e-book and leaflet for owners, and a social media toolkit with graphics and pre-written posts for practices to use on their own social media channels.
The company is also running its fireworks waiting room display competition this month, in which the five veterinary practices who make best use of the materials for creating a display in their waiting room will win one of five £100 Love 2 Shop vouchers.
There are bonus points for practices that build a den in the waiting room to demonstrate the benefits of having a safe haven for dogs to retreat to when fireworks are going off.
Veterinary professionals can post pictures of the dens and waiting room displays on the Adaptil Facebook page throughout October - www.facebook.com/AdaptilForDogs.
Ceva is running commercial offers in the run up to the firework season, which practices are being encouraged to pass to their clients.
To download the fireworks marketing support pack go to http://bit.ly/3RxGLza.
For further information, contact your Ceva territory manager or email cevauk@ceva.com.
‘RVN Starting out’ takes around 10 hours to complete and is free to access at: https://academy.rcvs.org.uk/
VN Futures Project Manager, Jill Macdonald, said: “Our RVN Starting Out course has been created to support adapting to professional responsibility, optimising workplace learning opportunities and working effectively as part of a team.
"The course also assists newly-registered nurses with building confidence and considering their career development.
"We have included learning on key areas such as reflective practice, workplace culture, quality improvement, clinical decision-making and assertive communication to reflect the responsibilities that veterinary nurses now undertake."
“The course is delivered over six modules which can be completed individually and accessed at any time to fit around busy work schedules.”